BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31507617)

  • 21. A bright future for cancer vaccines. Success in early trials suggests vaccines are the next step in cancer treatment.
    Duke Med Health News; 2008 Oct; 14(10):4-5. PubMed ID: 18927992
    [No Abstract]   [Full Text] [Related]  

  • 22. The revival of cancer vaccines - The eminent need to activate humoral immunity.
    Huijbers EJM; Griffioen AW
    Hum Vaccin Immunother; 2017 May; 13(5):1112-1114. PubMed ID: 28118089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccines.
    Schijns V; Tartour E; Michalek J; Stathopoulos A; Dobrovolskienė NT; Strioga MM
    Cytotherapy; 2014 Apr; 16(4):427-39. PubMed ID: 24280238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Peptide-based vaccine therapy for cancer patients].
    Yamada A
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():602-7. PubMed ID: 15861717
    [No Abstract]   [Full Text] [Related]  

  • 25. T-cell epitope peptide vaccines.
    Elsawa SF; Rodeberg DA; Celis E
    Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer vaccination progress.
    Pawelec G; Rees RC
    Trends Mol Med; 2002 Dec; 8(12):545-6. PubMed ID: 12470983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical cancer vaccine trials.
    Jäger E; Jäger D; Knuth A
    Curr Opin Immunol; 2002 Apr; 14(2):178-82. PubMed ID: 11869889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The next generation of vaccines for the treatment of cancer.
    Long L; Glover RT; Kaufman HL
    Curr Opin Mol Ther; 1999 Feb; 1(1):57-63. PubMed ID: 11249685
    [No Abstract]   [Full Text] [Related]  

  • 29. Vaccines: an innovative approach to treating cancer.
    Pazdur MP; Jones JL
    J Infus Nurs; 2007; 30(3):173-8. PubMed ID: 17505219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dendritic cell vaccines for cancer therapy.
    Sprinzl GM; Kacani L; Schrott-Fischer A; Romani N; Thumfart WF
    Cancer Treat Rev; 2001 Aug; 27(4):247-55. PubMed ID: 11545544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer vaccines: finding the best way to train the immune system.
    Goldman B
    J Natl Cancer Inst; 2002 Oct; 94(20):1523-6. PubMed ID: 12381703
    [No Abstract]   [Full Text] [Related]  

  • 32. Cancer vaccines: a promising cancer therapy against all odds.
    Silk AW; Finn OJ
    Future Oncol; 2007 Jun; 3(3):299-306. PubMed ID: 17547525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].
    Jäger E; Jäger D; Knuth A
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1011-6. PubMed ID: 11555776
    [No Abstract]   [Full Text] [Related]  

  • 34. Gene therapy: development of immunostimulatory treatments for cancer.
    Gilligan MG; Knox PG; Searle PF
    Biotechnol Genet Eng Rev; 2000; 17():497-529. PubMed ID: 11255679
    [No Abstract]   [Full Text] [Related]  

  • 35. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
    Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
    Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lessons learned from cancer vaccine trials and target antigen choice.
    Butterfield LH
    Cancer Immunol Immunother; 2016 Jul; 65(7):805-12. PubMed ID: 26842127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination with poly-L-arginine as immunostimulant for peptide vaccines: induction of potent and long-lasting T-cell responses against cancer antigens.
    Mattner F; Fleitmann JK; Lingnau K; Schmidt W; Egyed A; Fritz J; Zauner W; Wittmann B; Gorny I; Berger M; Kirlappos H; Otava A; Birnstiel ML; Buschle M
    Cancer Res; 2002 Mar; 62(5):1477-80. PubMed ID: 11888923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4 T cells and their role in antitumor immune responses.
    Toes RE; Ossendorp F; Offringa R; Melief CJ
    J Exp Med; 1999 Mar; 189(5):753-6. PubMed ID: 10049938
    [No Abstract]   [Full Text] [Related]  

  • 39. Dendritic cells for specific cancer immunotherapy.
    Meidenbauer N; Andreesen R; Mackensen A
    Biol Chem; 2001 Apr; 382(4):507-20. PubMed ID: 11405216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GM-CSF-based cancer vaccines.
    Dranoff G
    Immunol Rev; 2002 Oct; 188():147-54. PubMed ID: 12445288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.